Juliana Eng

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study”.

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

The Lancet(2023)10.1016/s0140-6736(23)01857-3

N/A

4.7DataRank · unranked

264 citations

Jonathan T. Yang, Juber Patel, Annemarie F. Shepherd, Juliana Eng, Randy Yeh +44 more

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02518-x

N/A

1.3DataRank · unranked

58 citations

Bharat Burman, Swati Jain, Conall Fitzgerald, Eric J. Sherman, Lara Dunn +24 more

Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.02.030

N/A

1.1DataRank · unranked

27 citations

Zachary Moore, Stephanie Lobaugh, Alexander Geyer, Daphna Y. Gelblum, Raja-Elie E. Abdulnour +23 more

A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3060

N/A

0.668DataRank · unranked

12 citations

Rachel K. Kim, Linda S. Ahn, Andrew J. Plodkowski, Ai Ni, Mark T.A. Donoghue +10 more

A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Oral Oncology(2025)10.1016/j.oraloncology.2025.107524

N/A

0DataRank · unranked

0 citations

Alan L. Ho, Loren S. Michel, Winston Wong, Juliana Eng, Iris Zhi +9 more

COVID-19 in patients with lung cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.06.007

N/A

0DataRank · unranked

270 citations

Hira Rizvi, Isabel R. Preeshagul, Jacklynn V. Egger, David Hoyos, Chai Bandlamudi +26 more

ALK Inhibitor Response in Novel ZFPM2::ALK and TRIM24::ALK Fusion-Positive Lung Cancers: Case Report

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100934

N/A

0DataRank · unranked

0 citations

Mohamed A. Yakoub, Michael Offin, Juliana Eng, Alexander Drilon, Soo-Ryum Yang +1 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Nature Medicine(2022)10.1038/s41591-022-02047-z

N/A

0DataRank · unranked

195 citations

Emily S. Lebow, Randy Yeh, Jeeban Paul Das, Azadeh Namakydoust, Paul K. Paik +67 more

Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0498

N/A

0DataRank · unranked

39 citations

Nicholas R. Waters, Natalie Smith, Anqi Dai, John Slingerland, Nathan Aleynick +24 more

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

Frontiers in Oncology(2023)10.3389/fonc.2023.1253629

N/A

0DataRank · unranked

18 citations

Narek Shaverdian, Jordan Eichholz, L.B. Kratochvil, Megan McCune, Yonina R. Murciano‐Goroff +27 more